(Q46497471)

22 December 2017

title

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience (English)

1 reference

22 December 2017

author name string

J T Wright

1

1 reference

22 December 2017

W C Cushman

2

1 reference

22 December 2017

B R Davis

3

1 reference

22 December 2017

J Barzilay

4

1 reference

22 December 2017

P Colon

5

1 reference

22 December 2017

D Egan

6

1 reference

22 December 2017

T Lucente

7

1 reference

22 December 2017

C Nwachuku

8

1 reference

22 December 2017

S Pressel

9

1 reference

22 December 2017

F H Leenen

10

1 reference

22 December 2017

J Frolkis

11

1 reference

22 December 2017

R Letterer

12

1 reference

22 December 2017

S Walsh

13

1 reference

22 December 2017

J N Tobin

14

1 reference

22 December 2017

G E Deger

15

1 reference

22 December 2017

ALLHAT Research Group

16

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

22 December 2017

Contemporary Clinical Trials

published in

1 reference

22 December 2017

volume

22

1 reference

22 December 2017

issue

6

1 reference

22 December 2017

page(s)

659-673

1 reference

22 December 2017

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

Randomised controlled trial of treatment for mild hypertension: design and pilot trial. Report of Medical Research Council Working Party on Mild to Moderate Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

Systolic Hypertension in the Elderly Program (SHEP). Part 2: Screening and recruitment.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

Systolic Hypertension in the Elderly Program (SHEP). Part 4: Baseline medical history findings

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial. The MRFIT Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

Hypertension detection and follow-up program. Baseline laboratory examination characteristics of the hypertensive participants

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

Analysis of the MRFIT screenees: a methodological study

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

Recruitment of participants for the multiple risk factor intervention trial (MRFIT)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2801%2900176-3

7 January 2021

10.1016/S0197-2456(01)00176-3

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017